Abstract
Bipolar disorders are prevalent and severe illnesses that are associated with a high risk of suicide. Patients with bipolar disorder who have had prior suicide attempts are at a substantially higher risk for future suicidality, even after controlling for other risk factors. Despite the magnitude of this problem, there is a paucity of controlled prospective data to guide clinical care, most likely due to the difficulties inherent in such studies. The most robust literature supports the use of lithium as a suicide-protective agent in bipolar disorder, but a definitive controlled study in a generalizable population is warranted. As in other areas of psychiatry, a careful assessment of the individual patient risk is of paramount importance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Angst F, Stassen HH, Clayton PJ, Angst J: Mortality of patients with mood disorders: follow-up over 34-38 years.J Affect Disord 2002,68:167–181.
Harris EC, Barraclough B: Suicide as an outcome for mental disorders. A meta analysis.Br J Psychiatry 1997,170:205–228.
Rihmer Z, Kiss K: Bipolar disorders and suicidal behaviour.Bipolar Disord 2002,4(Suppl 1):21–25.
Marangell LB, Bauer MS, Dennehy EB, et al.: Prospective predictors of suicide and suicide attempts in 1556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord 2006, In press.
Swann AC, Dougherty DM, Pazzaglia PJ, et al.: Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder.Am J Psychiatry 2005,162:1680–1687.
American Psychiatric Association: Practice guidelines for the assessment and treatment of patients with suicidal behaviors. In Practice Guidelines for the Treatment of Psychiatric Disorders Compendium. 2nd Ed. Arlington: American Psychiatric Association; 2004:835-1027.
Dilsaver SC, Chen YW, Swann AC, et al.: Suicidality in patients with pure and depressive mania.Am J Psychiatry 1994,151:1312–1315.
Sachs GS, Yan LJ, Swann AC, Allen MH: Integration of suicide prevention into outpatient management of bipolar disorder.J Clin Psychiatry 2001,62(Suppl 25):3–11.
Baldessarini RJ, Tondo L, Hennen J: Lithium treatment and suicide risk in major affective disorders: update and new findings.J Clin Psychiatry 2003,64(Suppl 5):44–52.
Goodwin FK, Fireman B, Simon GE, et al.: Suicide risk in bipolar during treatment with lithium and divalproex.JAMA 2003,290:1467–1473.
Cipriani A, Wilder H, Hawton K, Geddes J: Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomized trials.Am J Psychiatry 2005,162:1805–1819.
Simon NM, Otto MW, Wisniewski SR, et al.: Anxiety disorder comorbidity in bipolar disorder: data from the first 500 STEP-BD participants.Am J Psychiatry 2004,161:2222–2229.
Winokur G, Coryell W, Endicott J, Akiskal H: Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression).Am J Psychiatry 1993,150:1176–1181.
Regier DA, Farmer ME, Rae DS, et al.: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.JAMA 1990,264:2511–2518.
Henry C, Van den Bulke D, Bellivier F, et al.: Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.J Clin Psychiatry, 200364:331–335.
Salloum IM, Thase ME: Impact of substance abuse on the course and treatment of bipolar disorder.Bipolar Disord 2000,2:269–280.
Kessler RC, Frank RG: The impact of psychiatric disorders on work loss days.Psychol Med 1997,27:861–873.
Coryell W, Arndt S, Turvey C, et al.: Lithium and suicidal behavior in major affective disorder: a case-control study.ACTA Psychiatrica Scandinavic 2001,104:93–197.
Thies-Flechtner K, Muller-Oerlinghausen B, Seibert W, et al.: Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial.Pharmacopsychiatry 1996,29:103–107.
Meltzer HY, Alphs L, Green AI, et al.: Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).Arch Gen Psychiatry 2003,60:82–91.
Tollefson GD, Fawcett J, Winokur G, et al.: Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.Ann Clin Psychiatry 1993,5:209–224.
Bauer MS, Wisniewski SR, Marangell LB, et al.: Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).J Clin Psychiatry 2006,67:48–55.
Rucci P, Frank E, Kostelnik B, et al.: Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy.Am J Psychiatry 2002,159:1160–1164.
Linehan MM, Heard HL, Armstrong HE: Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients.Arch Gen Psychiatry 1993,50:971–974.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marangell, L.B., Martinez, J.M., Martinez, M. et al. Suicide risk and prevention in bipolar disorder. Current Psychosis & Therapeutics Reports 4, 167–170 (2006). https://doi.org/10.1007/BF02629391
Issue Date:
DOI: https://doi.org/10.1007/BF02629391